Stocks and Investing Stocks and Investing
Thu, March 10, 2022
Wed, March 9, 2022

Jacob Johnson Maintained (CDMO) at Buy with Decreased Target to $28 on, Mar 9th, 2022


Published on 2024-10-27 20:01:01 - WOPRAI, Jacob Johnson
  Print publication without navigation


Jacob Johnson of Stephens & Co., Maintained "Avid Bioservices, Inc." (CDMO) at Buy with Decreased Target from $31 to $28 on, Mar 9th, 2022.

Jacob has made no other calls on CDMO in the last 4 months.



There are 3 other peers that have a rating on CDMO. Out of the 3 peers that are also analyzing CDMO, 1 agrees with Jacob's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Paul Knight of "Keybanc" Downgraded from Buy to Hold on, Wednesday, December 8th, 2021


These are the ratings of the 2 analyists that currently disagree with Jacob


  • Matt Hewitt of "Craig-Hallum" Maintained at Strong Buy with Increased Target to $35 on, Wednesday, December 8th, 2021
  • Sean Dodge of "RBC Capital" Maintained at Buy with Increased Target to $32 on, Wednesday, December 8th, 2021
Contributing Sources